You are here


Partnering with NIH

We have a variety of agreements that allow companies, universities, and government agencies to leverage our unique and wide-ranging resources.
  • Your specific goals will determine the most appropriate agreement, whether a transactional agreement, a co-development agreement, or a research-use or commercialization license
  • Confidential Disclosure Agreement (CDA) allows you to discuss confidential or proprietary information with NIH employees, it limits the public release of the exchanged information, and either one-way or two-way agreements are possible.
  • If you are with a for-profit company:
    • A Biological Materials License is required for transfer of materials from NIH to a for-profit organization;
    • Collaboration Agreement is the simplest research collaboration agreement;
    • Cooperative Research and Development Agreement (CRADA) allows you to more broadly negotiate terms and conditions and provide resources;
    • A Clinical Trial Agreement (CTA) defines: who will perform a cllinical trial; who is responsible for providing the drug(s) or other materials; and who has responsibility for complying with Federal regulations on protecting human subjects;
    • Exclusive and non-exclusive licenses are available for commercialization of an NIH invention.
  • The NCI SBIR-Tech Transfer Program
  • If you are with a non-profit or university,Material Transfer Agreement (MTA) will be required for exchanging research materials with an NIH scientist in order to memorialize the transfer. This is critical if the materials are human-derived. 

Deciding which type of agreement to use can be a challenge. Therefore, the TTC highly recommends that you discuss your interests with TTC staff. If you do not have a TTC staff contact, please reach out to our Invention Development and Marketing Unit.